Albemarle Stock

$60.38

0.33% yesterday

NYSE, Jun 25, 10:10 pm CET

ISIN

US0126531013

Symbol

ALB

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Process industry

Industry

Chemistry

Overview Dividends Analysts Charts News Strategies

Albemarle Stock price

$60.38

-13.57 18.35% 5Y

NYSE, Closing price Wed, Jun 25 2025

+0.20 0.33%

ISIN

US0126531013

Symbol

ALB

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Process industry

Industry

Chemistry

Key metrics

Basic

Market capitalization

$7.1b

Enterprise Value

$9.1b

Net debt

$2.0b

Cash

$1.5b

Shares outstanding

117.7m

Valuation (TTM | estimate)

P/E

negative | negative

P/S

1.39 | 1.47

EV/Sales

1.79 | 1.88

EV/FCF

negative

P/B

0.71

Dividends

DPS

$1.61

Yield 1Y | 5Y

2.67% | 0.95%

Growth 1Y | 5Y

0.63% | 1.84%

Payout 1Y | 3Y

-14.38% | 19.16%

Increased

25 Years

Financials (TTM | estimate)

Revenue

$5.1b | $4.8b

EBITDA

$154.9m | $949.5m

EBIT

$-471.7m

Net Income

$-1.3b | $-227.6m

Free Cash Flow

$-139.6m

Growth (TTM | estimate)

Revenue

-39.34% | -9.90%

EBITDA

147.51% | 2,434.61%

EBIT

40.47%

Net Income

-501.41% | 82.70%

Free Cash Flow

91.33%

Margin (TTM | estimate)

Gross

3.53%

EBITDA

3.04% | 19.60%

EBIT

-9.26%

Net

-25.67% | -4.70%

Free Cash Flow

-2.74%

EPS

$-11.12

FCF per Share

$-1.19

Short interest

23.88%

Employees

8.30k

Rev per Employee

$650.00k

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Get Started for Free Today

Albemarle Stock Analysis

Unlock Scores for Free

??

27 Analysts have issued a Albemarle forecast:

8x Buy

30%

17x Hold

63%

More details on Analyst Estimates Including Price Targets

27 Analysts have issued a Albemarle forecast:

Buy

30%

Hold

63%

Sell

Analyst Estimates with Stock Price Targets

Financial data from Albemarle

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	5,094 5,094	39% 39% 100%
- Direct Costs	4,914 4,914	42% 42% 96%
Gross Profit	180 180	558% 558% 4%
- Selling and Administrative Expenses	574 574	14% 14% 11%
- Research and Development Expense	77 77	13% 13% 2%
EBITDA	155 155	148% 148% 3%
- Depreciation and Amortization	627 627	34% 34% 12%
EBIT (Operating Income) EBIT	-472 -472	40% 40% -9%
Net Profit	-1,307 -1,307	501% 501% -26%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Albemarle Stock News

Positive

Seeking Alpha

●

6 days ago

69 June Aristocrats: 1 To Buy

Five of the ten lowest-priced S&P 500 Dividend Aristocrats are currently attractive buys, offering high yields and fair valuations for income investors. Analyst forecasts suggest potential net gains of 15.65% to 36.53% for the top ten Aristocrat Dogs by June 2026, with average risk below the market. Fifteen Aristocrats show negative free cash flow margins, signaling caution—dividends may not be...

Positive

Seeking Alpha

●

7 days ago

Albemarle's Lithium Reset: Strong Buy Amid Cyclical Downturn And Structural Rebirth

We Initiate Albemarle at Strong Buy, $125 PT, citing deep undervaluation and robust volume growth from project ramps and cost discipline. ALB's volume-led strategy, contract coverage, and supply chain optimization position it for margin outperformance even in a flat lithium price environment. Disciplined capital allocation and cost savings drive strong cash conversion and liquidity, supporting ...

Positive

MarketBeat

●

7 days ago

3 Growth Stocks Too Small for Institutions to Buy

Most retail investors fall to the default belief that they do not have any competitive advantage compared to the world of hedge funds and investment banks, otherwise known as the smart money institutional players on Wall Street. While this is mostly true across the board, access to information, leverage of connections, and industry insights are not the only factors that can help retail investor...

More Albemarle News

Company Profile

Albemarle Corp. is a specialty company, which engages in developing, manufacturing, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment engages in developing and manufacture of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine Specialties segment consists of bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contain two product lines: clean fuels technologies, which is primarily composed of hydro processing catalysts, and heavy oil upgrading that comprises of fluidized catalytic cracking catalysts and additives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Head office	United States
CEO	Jerry Masters
Employees	8,300
Founded	1993
Website	www.albemarle.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now